Intravenous milrinone is no better than standard therapy for people admitted with acute exacerbation of chronic heart failure

M. Cuffe, R. Califf, K. Adams, R. Benza, R. Bourge, W. Colucci, B. Massie, C. O'Connor, I. Pina, R. Quigg, M. Silver, Mihai Gheorghiade, Marcus G. Hennersdorf

Research output: Contribution to journal › Short survey › peer-review

Fingerprint

Dive into the research topics of 'Intravenous milrinone is no better than standard therapy for people admitted with acute exacerbation of chronic heart failure'. Together they form a unique fingerprint.